Cargando…

Long-term transcriptomic and proteomic effects in Sprague Dawley rat thyroid and plasma after internal low dose (131)I exposure

BACKGROUND: Radioiodide ((131)I) is commonly used to treat thyroid cancer and hyperthyroidis.(131)I released during nuclear accidents, have resulted in increased incidence of thyroid cancer in children. Therefore, a better understanding of underlying cellular mechanisms behind (131)I exposure is of...

Descripción completa

Detalles Bibliográficos
Autores principales: Larsson, Malin, Rudqvist, Nils, Spetz, Johan, Shubbar, Emman, Parris, Toshima Z., Langen, Britta, Helou, Khalil, Forssell-Aronsson, Eva
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7774980/
https://www.ncbi.nlm.nih.gov/pubmed/33382739
http://dx.doi.org/10.1371/journal.pone.0244098
_version_ 1783630376256667648
author Larsson, Malin
Rudqvist, Nils
Spetz, Johan
Shubbar, Emman
Parris, Toshima Z.
Langen, Britta
Helou, Khalil
Forssell-Aronsson, Eva
author_facet Larsson, Malin
Rudqvist, Nils
Spetz, Johan
Shubbar, Emman
Parris, Toshima Z.
Langen, Britta
Helou, Khalil
Forssell-Aronsson, Eva
author_sort Larsson, Malin
collection PubMed
description BACKGROUND: Radioiodide ((131)I) is commonly used to treat thyroid cancer and hyperthyroidis.(131)I released during nuclear accidents, have resulted in increased incidence of thyroid cancer in children. Therefore, a better understanding of underlying cellular mechanisms behind (131)I exposure is of great clinical and radiation protection interest. The aim of this work was to study the long-term dose-related effects of (131)I exposure in thyroid tissue and plasma in young rats and identify potential biomarkers. MATERIALS AND METHODS: Male Sprague Dawley rats (5-week-old) were i.v. injected with 0.5, 5.0, 50 or 500 kBq (131)I (D(thyroid) ca 1–1000 mGy), and killed after nine months at which time the thyroid and blood samples were collected. Gene expression microarray analysis (thyroid samples) and LC-MS/MS analysis (thyroid and plasma samples) were performed to assess differential gene and protein expression profiles in treated and corresponding untreated control samples. Bioinformatics analyses were performed using the DAVID functional annotation tool and Ingenuity Pathway Analysis (IPA). The gene expression microarray data and LC-MS/MS data were validated using qRT-PCR and ELISA, respectively. RESULTS: Nine (131)I exposure-related candidate biomarkers (transcripts: Afp and RT1-Bb, and proteins: ARF3, DLD, IKBKB, NONO, RAB6A, RPN2, and SLC25A5) were identified in thyroid tissue. Two dose-related protein candidate biomarkers were identified in thyroid (APRT and LDHA) and two in plasma (DSG4 and TGM3). Candidate biomarkers for thyroid function included the ACADL and SORBS2 (all activities), TPO and TG proteins (low activities). (131)I exposure was shown to have a profound effect on metabolism, immune system, apoptosis and cell death. Furthermore, several signalling pathways essential for normal cellular function (actin cytoskeleton signalling, HGF signalling, NRF2-mediated oxidative stress, integrin signalling, calcium signalling) were also significantly regulated. CONCLUSION: Exposure-related and dose-related effects on gene and protein expression generated few expression patterns useful as biomarkers for thyroid function and cancer.
format Online
Article
Text
id pubmed-7774980
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-77749802021-01-11 Long-term transcriptomic and proteomic effects in Sprague Dawley rat thyroid and plasma after internal low dose (131)I exposure Larsson, Malin Rudqvist, Nils Spetz, Johan Shubbar, Emman Parris, Toshima Z. Langen, Britta Helou, Khalil Forssell-Aronsson, Eva PLoS One Research Article BACKGROUND: Radioiodide ((131)I) is commonly used to treat thyroid cancer and hyperthyroidis.(131)I released during nuclear accidents, have resulted in increased incidence of thyroid cancer in children. Therefore, a better understanding of underlying cellular mechanisms behind (131)I exposure is of great clinical and radiation protection interest. The aim of this work was to study the long-term dose-related effects of (131)I exposure in thyroid tissue and plasma in young rats and identify potential biomarkers. MATERIALS AND METHODS: Male Sprague Dawley rats (5-week-old) were i.v. injected with 0.5, 5.0, 50 or 500 kBq (131)I (D(thyroid) ca 1–1000 mGy), and killed after nine months at which time the thyroid and blood samples were collected. Gene expression microarray analysis (thyroid samples) and LC-MS/MS analysis (thyroid and plasma samples) were performed to assess differential gene and protein expression profiles in treated and corresponding untreated control samples. Bioinformatics analyses were performed using the DAVID functional annotation tool and Ingenuity Pathway Analysis (IPA). The gene expression microarray data and LC-MS/MS data were validated using qRT-PCR and ELISA, respectively. RESULTS: Nine (131)I exposure-related candidate biomarkers (transcripts: Afp and RT1-Bb, and proteins: ARF3, DLD, IKBKB, NONO, RAB6A, RPN2, and SLC25A5) were identified in thyroid tissue. Two dose-related protein candidate biomarkers were identified in thyroid (APRT and LDHA) and two in plasma (DSG4 and TGM3). Candidate biomarkers for thyroid function included the ACADL and SORBS2 (all activities), TPO and TG proteins (low activities). (131)I exposure was shown to have a profound effect on metabolism, immune system, apoptosis and cell death. Furthermore, several signalling pathways essential for normal cellular function (actin cytoskeleton signalling, HGF signalling, NRF2-mediated oxidative stress, integrin signalling, calcium signalling) were also significantly regulated. CONCLUSION: Exposure-related and dose-related effects on gene and protein expression generated few expression patterns useful as biomarkers for thyroid function and cancer. Public Library of Science 2020-12-31 /pmc/articles/PMC7774980/ /pubmed/33382739 http://dx.doi.org/10.1371/journal.pone.0244098 Text en © 2020 Larsson et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Larsson, Malin
Rudqvist, Nils
Spetz, Johan
Shubbar, Emman
Parris, Toshima Z.
Langen, Britta
Helou, Khalil
Forssell-Aronsson, Eva
Long-term transcriptomic and proteomic effects in Sprague Dawley rat thyroid and plasma after internal low dose (131)I exposure
title Long-term transcriptomic and proteomic effects in Sprague Dawley rat thyroid and plasma after internal low dose (131)I exposure
title_full Long-term transcriptomic and proteomic effects in Sprague Dawley rat thyroid and plasma after internal low dose (131)I exposure
title_fullStr Long-term transcriptomic and proteomic effects in Sprague Dawley rat thyroid and plasma after internal low dose (131)I exposure
title_full_unstemmed Long-term transcriptomic and proteomic effects in Sprague Dawley rat thyroid and plasma after internal low dose (131)I exposure
title_short Long-term transcriptomic and proteomic effects in Sprague Dawley rat thyroid and plasma after internal low dose (131)I exposure
title_sort long-term transcriptomic and proteomic effects in sprague dawley rat thyroid and plasma after internal low dose (131)i exposure
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7774980/
https://www.ncbi.nlm.nih.gov/pubmed/33382739
http://dx.doi.org/10.1371/journal.pone.0244098
work_keys_str_mv AT larssonmalin longtermtranscriptomicandproteomiceffectsinspraguedawleyratthyroidandplasmaafterinternallowdose131iexposure
AT rudqvistnils longtermtranscriptomicandproteomiceffectsinspraguedawleyratthyroidandplasmaafterinternallowdose131iexposure
AT spetzjohan longtermtranscriptomicandproteomiceffectsinspraguedawleyratthyroidandplasmaafterinternallowdose131iexposure
AT shubbaremman longtermtranscriptomicandproteomiceffectsinspraguedawleyratthyroidandplasmaafterinternallowdose131iexposure
AT parristoshimaz longtermtranscriptomicandproteomiceffectsinspraguedawleyratthyroidandplasmaafterinternallowdose131iexposure
AT langenbritta longtermtranscriptomicandproteomiceffectsinspraguedawleyratthyroidandplasmaafterinternallowdose131iexposure
AT heloukhalil longtermtranscriptomicandproteomiceffectsinspraguedawleyratthyroidandplasmaafterinternallowdose131iexposure
AT forssellaronssoneva longtermtranscriptomicandproteomiceffectsinspraguedawleyratthyroidandplasmaafterinternallowdose131iexposure